Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 50Endocrine 50Gynecologic 5Thoracic 4CNS 4Gastrointestinal 3Plasma cell 2Other hematologic neoplasm 2NET 2Myeloid 2Sarcoma 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Leukemia, Myeloid, Acute 2265Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Leukemia 1500Leukemia, Lymphocytic, Chronic, B-Cell 1120Myelodysplastic Syndromes 963Hematologic Neoplasms 935Lymphoma 739Lymphoma, Non-Hodgkin 654Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Multiple Myeloma 501Lymphoma, Follicular 467Hodgkin Disease 460Lymphoma, Mantle-Cell 459Burkitt Lymphoma 440Lymphoma, Large B-Cell, Diffuse 433Lymphoma, B-Cell, Marginal Zone 402Recurrence 356Leukemia, Myelomonocytic, Chronic 351Myeloproliferative Disorders 330Leukemia, Myeloid, Chronic-Phase 311Lymphoma, Large-Cell, Immunoblastic 303Congenital Abnormalities 273Neoplasms 271Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Blast Crisis 246Leukemia, Myeloid, Accelerated Phase 244Primary Myelofibrosis 221Neoplasms, Plasma Cell 220Waldenstrom Macroglobulinemia 216Lymphoma, T-Cell, Cutaneous 197

Interventions

trametinib 1dabrafenib 1cobimetinib 1Vemurafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Thyroid Carcinoma, Anaplastic × Other hematologic neoplasm × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT05768178 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡